| Identification | Back Directory | [Name]
Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione, 7-chloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-, (1R)- | [CAS]
2300966-23-6 | [Synonyms]
7-chloro-6-fluoro-(1M)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione
Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione, 7-chloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-, (1R)- | [Molecular Formula]
C16H14ClFN4O2 | [MOL File]
2300966-23-6.mol | [Molecular Weight]
348.76 |
| Chemical Properties | Back Directory | [density ]
1.397±0.06 g/cm3(Predicted) | [pka]
6.91±0.20(Predicted) | [InChI]
InChI=1S/C16H14ClFN4O2/c1-7(2)11-12(8(3)4-5-19-11)22-14-9(15(23)21-16(22)24)6-10(18)13(17)20-14/h4-7H,1-3H3,(H,21,23,24) | [InChIKey]
OXJTVPMAMRSGNT-UHFFFAOYSA-N | [SMILES]
O=C1NC(=O)C2=CC(F)=C(Cl)N=C2N1C1C(=CC=NC=1C(C)C)C |
| Hazard Information | Back Directory | [Definition]
(1R)-7-Chloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione is an intermediate of Sotorasib which is used to treat a particular type of lung cancer. |
|
|